Anti-VEGF for Diabetic Macular Edema

Published by Dr. Manolette Roque at March 10, 2026

Anti-VEGF for Diabetic Macular Edema

🤖 Quick Answer: Anti-VEGF treatment for diabetic macular edema uses medicines injected into the eye to reduce retinal leakage and swelling. These injections often help stabilize or improve vision, especially when the center of the macula is involved. Most patients need repeated treatment and regular OCT monitoring, not just one injection, to achieve the best long-term results.

When diabetes causes fluid to collect in the center of the retina, vision can become blurry, distorted, or less sharp for reading and driving. This condition is called diabetic macular edema (DME). Today, one of the most important treatments for DME is anti-VEGF therapy.

This guide explains what anti-VEGF means, how the injections work, who may benefit, what happens during treatment, what risks to know, and why repeated follow-up matters. The goal is simple: help patients understand the treatment clearly and make informed decisions without fear.

🧩 Focus: Anti-VEGF therapy for diabetic macular edema
👁 Goal: Explain how intravitreal injections reduce macular swelling and protect vision
🛡 Evidence-Based: Preferred Practice Patterns • Standards of Care • Systematic Reviews • Meta-Analyses

🧠 Diabetic Eye Disease Knowledge Hub

Start with the complete guide:
Diabetic Eye Disease: The Complete Patient Guide

📌 Key Learning Points

Anti-VEGF injections are a main treatment for diabetic macular edema, especially when the center of vision is affected.
The medicine is injected inside the eye under sterile conditions after numbing drops are used.
Most patients need more than one injection because DME is a chronic disease, not a one-time problem.
OCT scans help your doctor measure retinal swelling and decide whether treatment should continue, pause, or change.
Good blood sugar, blood pressure, and kidney control can improve the odds of better visual outcomes.

👁 What Is Anti-VEGF?

VEGF stands for vascular endothelial growth factor. This is a protein that can increase leakage from retinal blood vessels and promote abnormal vessel growth. In diabetic macular edema, too much VEGF can worsen retinal swelling.

Anti-VEGF medicines are designed to block this leakage signal. They are given by intravitreal injection, which means the medicine is placed directly inside the eye so it can reach the retina effectively.

Common anti-VEGF medicines used in retinal practice include:

Vabysmo (faricimab)
Eylea (aflibercept)
Lucentis (ranibizumab)
Avastin (bevacizumab) in settings where it is used off-label in retina practice

💡 Analogy: Imagine the macula as the sharpest part of a camera sensor. DME is like water leaking under that sensor. Anti-VEGF treatment helps “turn down the leaking tap,” so the swelling can go down and the picture can become clearer.

👀 Why Anti-VEGF Helps in DME

DME happens when damaged diabetic retinal blood vessels leak fluid into the macula. If the center of the macula becomes swollen, patients may notice blurred reading vision, distorted letters, poor face recognition, or difficulty driving.

Anti-VEGF injections help by:

reducing vessel leakage
reducing retinal swelling
stabilizing the blood-retina barrier
sometimes improving vision when treatment begins early enough

However, anti-VEGF is not a “magic reset button.” Some patients improve quickly, some improve slowly, and some mainly achieve stabilization rather than dramatic vision gain. The starting vision, OCT findings, duration of swelling, and overall diabetic control all matter.

For a broader explanation of swelling in the macula, read Diabetic Macular Edema Explained and OCT for Diabetic Macular Edema.

Who May Need This Treatment?

Anti-VEGF is commonly considered when diabetic macular edema affects vision or when OCT shows swelling involving the center of the macula. Doctors often pay special attention to center-involving DME, because this area controls detailed vision.

You may be a candidate for anti-VEGF treatment if:

your OCT shows macular swelling from diabetes
your central vision is reduced or threatened
your retina specialist believes injection therapy offers the best first-line option
laser alone is unlikely to control the swelling adequately

Anti-VEGF may still help even if your vision is not yet severely blurred, especially when the doctor is trying to protect central vision early. That said, treatment decisions should always be individualized.

In some situations, your doctor may instead recommend or combine treatment with:

focal laser for DME
intravitreal steroid therapy
observation with close follow-up if swelling is mild and vision is still excellent

🧪 What Happens During the Injection Visit?

Many patients feel anxious the first time they hear “injection inside the eye.” In reality, the visit is usually brief and highly standardized.

Typical steps during the visit

Your vision and eye pressure may be checked.
The eye is cleaned carefully using antiseptic measures.
Numbing drops are applied so the injection is more comfortable.
An eyelid holder may be used to keep the eye open.
The medication is injected through the white part of the eye.
The eye is rechecked, and you are given instructions for warning symptoms afterward.

Most patients describe the treatment as strange or uncomfortable rather than severely painful. The actual injection usually takes only a few seconds.

For a full visit-by-visit explanation, see Anti-VEGF Injection Procedure.

How Many Injections Are Usually Needed?

This is one of the most important questions patients ask. The honest answer is: it depends. DME is often a chronic disease. Because of that, treatment usually involves an initial series followed by ongoing monitoring and repeat injections as needed.

In practical terms, many patients begin with a loading phase or close interval treatment, then move into a maintenance phase based on OCT and vision results. Some need frequent injections for a long time. Others can stretch intervals once swelling is controlled.

Your doctor may use one of several strategies:

fixed interval treatment
treat-and-extend style interval adjustments
as-needed retreatment based on OCT or vision findings

Learn more in Anti-VEGF Treatment Schedule.

Why repeat treatment matters: One injection may reduce swelling, but it does not “cure” diabetes in the retina. If follow-up stops too early, fluid may return and vision may worsen again.

💊 Benefits and Limits of Anti-VEGF Treatment

Main benefits

can reduce retinal thickening on OCT
can stabilize vision
can improve vision in many patients, especially when treatment begins before permanent damage develops
can sometimes reduce the severity of diabetic retinopathy along with treating edema

Important limits

treatment often requires repeated visits
not every patient gains many lines of vision
if the retina has longstanding structural damage, recovery may be limited
systemic diabetic control still matters; injections alone are not enough

Some patients respond better to one anti-VEGF medicine than another. Others may eventually need the treatment plan changed to a steroid or laser-based strategy if the response is incomplete.

Drug-specific guides: Vabysmo • Eylea • Lucentis • Avastin

Risks and Side Effects

Anti-VEGF injections are widely used in retina practice, but no invasive treatment is risk-free. Most visits are uneventful, yet patients should understand the difference between common short-term irritation and true warning signs.

Common temporary effects

mild scratchy sensation
small red spot on the white of the eye
temporary blur right after the visit
awareness of new bubbles or specks for a short time

Serious but less common risks

infection inside the eye
significant inflammation
retinal tear or detachment
traumatic lens injury in rare situations
pressure spike inside the eye

🚨 Emergency Warning
Seek urgent ophthalmic evaluation after an injection if you develop severe eye pain, worsening redness, rapidly worsening vision, marked light sensitivity, or a sudden curtain/shadow in vision. These symptoms should not be ignored.

If you also have a history of glaucoma or high eye pressure, discuss that with your doctor before treatment. Related reading: Diabetes and Glaucoma • Neovascular Glaucoma in Diabetes

How to Improve Treatment Results

The injection treats the eye directly, but the body still matters. Patients often do best when retina treatment is combined with stronger diabetes control and better systemic care.

keep blood sugar as stable as possible
control blood pressure and cholesterol
follow the OCT and injection schedule closely
do not stop follow-up just because vision feels “better”
coordinate with your internist or endocrinologist

Continue Reading

🏁 Take-Home Message

Anti-VEGF treatment is one of the most important ways to manage diabetic macular edema and protect central vision. It works best when patients start early, return consistently for OCT-guided follow-up, and understand that DME usually needs ongoing management rather than a one-time injection.

If your doctor recommends anti-VEGF, think of it as part of a long-term retina care plan—together with better diabetes control, regular monitoring, and prompt reporting of warning symptoms.

❓ Frequently Asked Questions

Is anti-VEGF the same as laser treatment?
No. Anti-VEGF is medicine injected into the eye, while laser uses light energy to treat selected retinal problems. Some patients need one treatment, and others need both.

Will one injection cure diabetic macular edema?
Usually not. DME often needs repeated treatment and OCT monitoring because swelling can return.

Are anti-VEGF injections painful?
Most patients feel pressure, brief discomfort, or irritation rather than severe pain because numbing drops are used.

How soon can vision improve after starting treatment?
Some patients notice improvement within weeks, while others improve more gradually over several visits.

What if anti-VEGF is not enough?
Your retina specialist may consider changing the medicine, adjusting the interval, adding laser, or using a steroid-based option in selected cases.

Can anti-VEGF also help diabetic retinopathy, not just DME?
Yes. In some eyes, anti-VEGF treatment can also reduce the severity of diabetic retinopathy while treating the edema.

📚 References

American Academy of Ophthalmology Preferred Practice Pattern: Diabetic Retinopathy.
American Diabetes Association Standards of Care: Retinopathy section.
National Eye Institute: Diabetic Retinopathy / Diabetic Eye Disease.
DRCR Retina Network and major randomized clinical trials on DME therapy.
FDA and regulatory review materials for faricimab, aflibercept, and ranibizumab indications related to diabetic macular edema.

🤝 Roque Eye Clinic Patient Education Series

Reviewed by the Roque Advisory Council
Dr Manolette Roque | Dr Barbara Roque
St Luke’s Medical Center Global City | Asian Hospital Medical Center
Philippines

Medical Review: Roque Advisory Council
Last Updated: March 2026

This article is intended for educational purposes only and does not replace professional medical consultation.

ANIMATION

Intravitreal Injection
IVI Risks

BOOK AN APPOINTMENT

It takes less than 5 minutes to complete your online booking. Alternatively, you may call our BGC Clinic, or our Alabang Clinic for assistance.

Dr. Manolette Roque

Dr. Manolette Roque is an ophthalmologist whose practice includes general ophthalmology (which includes cataract surgery) with subspecialty work in uveitis and ocular immunology, cornea and external disease, and refractive surgery.